1 Department of Cardiology Amiens University Hospital Amiens France.
2 EA 7517 MP3CV Jules Verne University of Picardie Amiens France.
J Am Heart Assoc. 2019 Mar 19;8(6):e011036. doi: 10.1161/JAHA.118.011036.
Background Moderate aortic stenosis ( MAS ) has not been extensively studied and characterized, as no published study has been specifically devoted to this condition. Methods and Results We aimed to describe the characteristics of patients with MAS and to evaluate their long-term survival compared with that of the general population. This study included 508 patients (mean±SD age, 75±11 years) with MAS (aortic valve area between 1 and 1.5 cm; mean±SD aortic valve area, 1.2±0.15 cm) and preserved left ventricular ejection fraction. Patients were mostly (86.4%) asymptomatic or minimally symptomatic, 78.3% had hypertension, 36.2% were diabetics, and 48.3% had dyslipidemia. Each patient with MAS was matched for the average survival (per year) of all patients of the same age and same sex from our region (Somme department, north of France). During follow-up (median 47 months), 113 patients (22.2%) underwent aortic valve replacement for severe AS. The mean±SD time between inclusion and surgery was 37±22 months. During follow-up, 255 patients (50.2%) died. The 6-year survival of patients with MAS was lower than the expected survival (53±2% versus 65%). In multivariate analysis, age (hazard ratio, 1.04 [95% CI, 1.02-1.05]; P<0.001), prior atrial fibrillation (hazard ratio, 1.35 [95% CI, 1.05-1.73]; P=0.019), and Charlson comorbidity index (hazard ratio, 1.11 [95% CI, 1.05-1.18]; P=0.002) were associated with increased mortality. Aortic valve replacement was associated with better survival (hazard ratio, 0.38 [95% CI, 0.27-0.54]; P<0.001). Conclusions The results of this study show that patients with MAS present many cardiovascular risk factors, a high rate of surgery during follow-up, and increased mortality compared with the general population mainly related to associated comorbidities. Patients with MAS should, therefore, be managed for their cardiovascular risk factors and comorbidities. They require close follow-up, especially when the aortic valve area is close to 1 cm, as aortic valve replacement performed when patients transition to severe AS and develop indications for surgery during follow-up is associated with better survival.
背景 中度主动脉瓣狭窄(MAS)尚未得到广泛研究和描述,因为尚无专门针对这种情况的研究。
方法和结果 我们旨在描述 MAS 患者的特征,并评估其与普通人群相比的长期生存情况。本研究纳入了 508 例 MAS 患者(平均年龄 75±11 岁),其主动脉瓣面积为 1 至 1.5cm;平均主动脉瓣面积为 1.2±0.15cm)和保留左心室射血分数。患者大多(86.4%)无症状或仅有轻微症状,78.3%患有高血压,36.2%患有糖尿病,48.3%患有血脂异常。每位 MAS 患者均与来自法国北部索姆省(Somme department)的同年龄和同性别患者的平均生存时间(每年)相匹配。在随访期间(中位时间为 47 个月),113 例(22.2%)患者因严重 AS 行主动脉瓣置换术。纳入与手术之间的平均时间为 37±22 个月。随访期间,255 例(50.2%)患者死亡。MAS 患者的 6 年生存率低于预期生存率(53±2%比 65%)。多变量分析显示,年龄(风险比,1.04[95%CI,1.02-1.05];P<0.001)、先前的心房颤动(风险比,1.35[95%CI,1.05-1.73];P=0.019)和 Charlson 合并症指数(风险比,1.11[95%CI,1.05-1.18];P=0.002)与死亡率增加相关。主动脉瓣置换术与生存改善相关(风险比,0.38[95%CI,0.27-0.54];P<0.001)。
结论 本研究结果表明,MAS 患者存在许多心血管危险因素,随访期间手术率较高,死亡率高于普通人群,主要与相关合并症有关。因此,MAS 患者应针对其心血管危险因素和合并症进行管理。他们需要密切随访,特别是当主动脉瓣面积接近 1cm 时,因为当患者过渡到严重 AS 并在随访期间出现手术指征时进行主动脉瓣置换术与生存改善相关。